Featured Topics
Q2 2025
August 06, 2025
Q2 2025 Results
Calendar

July 15, 2025

Quiet Period (July 15 - August 06)

August 06, 2025

Press Releases
Share Price / Index
July 21, 2025
Not intended for U.S. and UK Media
Bayer’s Nubeqa™ (darolutamide) receives EU approval in third indication for patients with advanced prostate cancer
July 16, 2025
Far-reaching transformation advancing, delivering first signs of success:
Supervisory Board of Bayer AG extends contract of CEO Bill Anderson
July 14, 2025
Not intended for U.S. and UK Media
U.S. FDA Approves Finerenone for New Indication in Patients with Heart Failure with Left Ventricular Ejection Fraction of ≥ 40%

Our Products

Our broad product portfolio includes many world-famous brands that have shaped our Bayer brand. With our products, we are helping to find solutions to some of the greatest challenges of our time. So that health and nutrition can be made available to everyone.